Newsletter

Growblox Sciences, Inc. (GBLX)
Growblox Sciences, a biopharmaceutical research and development company, is focused on creating safe, standardized pharmaceutical-grade cannabis-based therapies for various medical conditions. The company is pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm to bring relief to patients in communities across the country.
View The Full Company Profile

GBLX: QualityStocks will receive $15,000 from GBLX for 90 days of advertising, branding, marketing, investor relations and social media services provided by QualityStocks and affiliate DreamTeam Brands. Please read entire QualityStocks Disclaimer for FULL Compensation Disclosures.

Cleartronic, Inc. (CLRI)
 IFAN Financial, Inc. (IFAN)
 International Stem Cell Corp. (ISCO)
MIT Holding, Inc. (MITD)
 Sibling Group Holdings, Inc. (SIBE)
 VistaGen Therapeutics Inc. (VSTA)

 Know of a stock poised to make a big move? Tell us which one and why! We're constantly scanning the headlines and keeping tabs on what's hot, but can always use an extra hand. Whether amateur or pro, you're more than welcome to join in on the fun!

 Micro-cap stocks can make rapid moves of 50% or more, making the latest information extremely critical to maximizing profits.

DTG, 7399 North Shadeland Ave, Indianapolis, Indiana 46250, USA 

Stocks covered:	Compensation:	Avg $ Volume for Period:
GBLX	$15000	UNKNOWN
Max Profit: 3.23 %	Gain at close: -11.83 %
*We think that this promoter is a part of a group of promoters.

Newsletter

Growblox Sciences, Inc. (GBLX) - Tip of the Week May 26, 2015 08:32